Jeil Pharma Holdings (XKRX:002620) Additional Paid-In Capital : ₩196,007 Mil(As of Mar. 2024)

View and export this data going back to 1988. Start your Free Trial

What is Jeil Pharma Holdings Additional Paid-In Capital?

Jeil Pharma Holdings's quarterly additional paid-in capital increased from Sep. 2023 (₩195,615 Mil) to Dec. 2023 (₩196,007 Mil) but then stayed the same from Dec. 2023 (₩196,007 Mil) to Mar. 2024 (₩196,007 Mil).

Jeil Pharma Holdings's annual additional paid-in capital declined from Dec. 2021 (₩195,869 Mil) to Dec. 2022 (₩195,544 Mil) but then increased from Dec. 2022 (₩195,544 Mil) to Dec. 2023 (₩196,007 Mil).

Jeil Pharma Holdings Additional Paid-In Capital Historical Data

The historical data trend for Jeil Pharma Holdings's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jeil Pharma Holdings Additional Paid-In Capital Chart

Jeil Pharma Holdings Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Additional Paid-In Capital

Get a 7-Day Free Trial

188,300.35

193,475.67

195,869.29

195,543.53

196,007.30

Jeil Pharma Holdings Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Additional Paid-In Capital	Get a 7-Day Free Trial															195,543.53	195,614.85	195,614.85	196,007.30	196,007.30

Jeil Pharma Holdings Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

Jeil Pharma Holdings Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Jeil Pharma Holdings's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Jeil Pharma Holdings (XKRX:002620) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jeil Pharma Holdings Inc (XKRX:002620) » Definitions » Additional Paid-In Capital

Traded in Other Exchanges

N/A

Address

745-5, Banpo-dong, Seocho-gu, Seoul, KOR, 137-810

Website

https://www.jeilpharm.co.kr

Jeil Pharma Holdings Inc is involved in manufacture and distribution of pharmaceutical products. The company mainly produces finished pharmaceutical products and active pharmaceutical ingredients. It has categorized its products in Antibiotic, Oncology, Cardiovascular, Gastrointestinal, Urology, Respiratory etc. The firm's manufacturing facility and research and development institute located at Yongin-si, Gyeonggi-do in Korea.

Jeil Pharma Holdings (XKRX:002620) Headlines

No Headlines